FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/23/2026
ANI Pharma (NASDAQ: ANIP) reported Q3 EPS of $0.64, $0.11 better than the analyst estimate of $0.53. Revenue for the quarter came in at $83.8 million versus the consensus estimate of $77.2 million.
GUIDANCE:
ANI Pharma sees FY2022 EPS of $1.34-$1.62, versus the consensus... More

